Took place2nd editionGastroenterology & Hepatology

2nd Intenational Conference on Pancreatic Disorders & Treatment

When
Sep 13–14, 2017

Programme

28 sessions

28 sessions

Scientific Tracks Abstracts

  1. Pancreatic cancer, the most lethal cancer todaySally Hodges
  2. Targeted therapeutics in pancreatic cancer for precision medicineSorah Yoon
  3. Targeting senescence associated inflammation to prevent pancreatic cancer progressionGregory David, Lau L, Porciuncula A, Rielland M, Cantor D J, Graveline R, Hajdu C, Mara L, de Diego Diaz B, Miller G
  4. High expression of galectin-1 in pancreatic stellate cells increases the progression of pancreatic cancerDong Tang
  5. Pancreas transplantationPradeep Kumar Vaitla
  6. Circulating biomarkers for early detection of pancreatic cancerPamela L Paris
  7. Acute cellular and antibody-mediated rejection of the pancreas allograft: Pathology, risk factors and outcomesJose R Torrealba
  8. Critical acute pancreatitisFilipa Ribeiro Crespo Lucas
  9. DDR1 inhibition as a strategy enhancing chemoresponse in pancreatic cancerHuocong Huang
  10. Transition from an open to a robotic pancreas surgery centerVichin C Puri
  11. Pancreatic Neuroendocrine Tumor diagnosis in the age of precision medicineDeepthi Rao
  12. Observation on the therapeutic effects of somatostatin injected in different rates on the fat-derived severe acute pancreatitis during hemoperfusionHaitao Shen

Keynote

  1. Human iPS cells are an alternative source of pancreatic beta cellsNicholas Zavazava
  2. Developing therapy-responsive prognostic biomarkers, and conquering undruggable oncogenic k-ras-driven pancreatic cancer by attacking its major k-ras vulnerability and the k-ras signaling gatekeeper - the siah proteolysiAmy H Tang

Posters & Accepted Abstracts

  1. Use of differential temperature evaluation as feedback for insulin delivery monitoring in acute severe (life threatening) glucose metabolism disordersV Coulic, VK Novikov, SA Dobos, J Devriendt
  2. Pancreas transplantation: The psychosocial assessment and determinants of candidacyDeborah Valentino
  3. Major venous resection/repair effect on survival of patients who have pancreatic adenocarcinoma with venous involvementHosein Shokouh-Amiri
  4. Role of miR-29 in pancreatic cancer and its potential use as a therapeutic agentJanaiah Kota
  5. Are incretins promoters or initiators of pancreatic cancer?Parviz M Pour
  6. Uncovering and characterizing a biomarker in pancreatic cancer patientsQingfeng Zhu, Shantel Angstadt, Elizabeth D Thompson, Douglas Robinson, Dung Le, Daniel A Laheru, Elizabeth M Jaffee, Robert A Anders
  7. Pathological evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas: the correlation and analyzes of the hispathotologic patternsCarolin Desire Nava Perez
  8. Acute pancreatitis after short and long-term use of 5-amino-salicylic acidMohamed Ahmed Ali Bassiony
  9. Hormonal manipulation induces differentiation of pancreatic progenitor cells into insulin-secreting islet β-cellsGuoli Huai
  10. Role of melatonin and its metabolite AFMK in the pancreatic protection and pancreatic exocrine functionJaworek J Szklarczyk J, Kot M, Nawrot-Porabka K, Bonior J, Goralska M, Leja-Szpak A, Pierzchalski P
  11. Tropical pancreatitis and idiopathic pancreatitis in IndiaRajesh Gopalakrishna

Recap

28 abstracts presented at this edition, linked from the programme.

Talks and sessions
28
Tracks
3
Abstracts held here
28

Tracks, and how many items each carried

  • Scientific Tracks Abstracts15
  • Posters & Accepted Abstracts11
  • Keynote2

Keynotes and plenaries, as the programme printed them

  • Human iPS cells are an alternative source of pancreatic beta cellsNicholas Zavazava
  • Developing therapy-responsive prognostic biomarkers, and conquering undruggable oncogenic k-ras-driven pancreatic cancer by attacking its major k-ras vulnerability and the k-ras signaling gatekeeper - the siah proteolysiAmy H Tang

Names as printed in the programme. Longdom adds no affiliation to them.

No session summary has been checked for this event yet.

What this programme does not say
  • The programme does not say how many people attended, and Longdom keeps no record of who attended.
  • Nothing here comes from a recording, a transcript or the discussion in the room: there are none.
  • The programme as published prints no times.

A programme is published for about one past event in five, so a digest is not available for every event.

Website and contact

Sponsor, exhibit or ask

This edition has ended. You can still send the organisers a question.

Something wrong on this page?

Tell the Longdom team about a wrong date or place, a broken link, or anything else.

Journals and research